Our present results are slightly different from those of previous studies, in which the decrease in eNOS expression has been demonstrated in patients with mild-to-moderate COPD and even in smokers with normal lung function (Barberà et al. 2001). Here, NOS3 is linked to chronic obstructive pulmonary disease.